BG
Bollard Group Portfolio holdings
AUM
$4.22B
1-Year Return
25.77%
This Quarter Return
+7.37%
1 Year Return
+25.77%
3 Year Return
+123.03%
5 Year Return
+181.1%
10 Year Return
+451.12%
AUM
$2.94B
AUM Growth
+$171M
(+6.2%)
Cap. Flow
-$9.27M
Cap. Flow
% of AUM
-0.32%
Top 10 Holdings %
Top 10 Hldgs %
68.26%
Holding
686
New
394
Increased
226
Reduced
9
Closed
3
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$1.45M |
| 2 |
Verizon
VZ
|
+$1.06M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$809K |
| 4 |
Southern Copper
SCCO
|
+$729K |
| 5 |
Enterprise Products Partners
EPD
|
+$633K |
Top Sells
| 1 |
Boston Scientific
BSX
|
+$23.4M |
| 2 |
Union Pacific
UNP
|
+$840K |
| 3 |
Target
TGT
|
+$747K |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$145K |
| 5 |
KeyCorp
KEY
|
+$99.6K |
Sector Composition
| 1 | Healthcare | 51.92% |
| 2 | Energy | 8.79% |
| 3 | Technology | 8.39% |
| 4 | Utilities | 7.86% |
| 5 | Industrials | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Cigna
CI
$80.7B
| $10K | ﹤0.01% |
+35
| New | +$10K |
|
302
KLA
KLAC
$122B
| $10K | ﹤0.01% |
+20
| New | +$10K |
|
303
Soleno Therapeutics
SLNO
$3.19B
| $10K | ﹤0.01% |
2,288
| – | – |
|
304
SM Energy
SM
$3.15B
| $10K | ﹤0.01% |
+302
| New | +$10K |
|
|
UNIT
305
Uniti Group
UNIT
$1.71B
| $10K | ﹤0.01% |
2,112
| – | – |
|
306
Performance Food Group
PFGC
$16.3B
| $10K | ﹤0.01% |
+164
| New | +$10K |
|
307
Raymond James Financial
RJF
$33.1B
| $10K | ﹤0.01% |
+94
| New | +$10K |
|
308
British American Tobacco
BTI
$123B
| $9K | ﹤0.01% |
+269
| New | +$9K |
|
309
Datadog
DDOG
$48.8B
| $9K | ﹤0.01% |
94
| – | – |
|
310
Devon Energy
DVN
$22.5B
| $9K | ﹤0.01% |
+185
| New | +$9K |
|
311
Consolidated Edison
ED
$35B
| $9K | ﹤0.01% |
+100
| New | +$9K |
|
312
Eaton
ETN
$140B
| $9K | ﹤0.01% |
+45
| New | +$9K |
|
313
GE Aerospace
GE
$298B
| $9K | ﹤0.01% |
+107
| New | +$9K |
|
314
MetLife
MET
$52.8B
| $9K | ﹤0.01% |
+155
| New | +$9K |
|
315
UBS Group
UBS
$127B
| $9K | ﹤0.01% |
+463
| New | +$9K |
|
316
Bruker
BRKR
$4.63B
| $8K | ﹤0.01% |
+110
| New | +$8K |
|
317
DigitalOcean
DOCN
$3.12B
| $8K | ﹤0.01% |
199
| – | – |
|
318
Equinix
EQIX
$76.8B
| $8K | ﹤0.01% |
+10
| New | +$8K |
|
319
HSBC
HSBC
$237B
| $8K | ﹤0.01% |
+201
| New | +$8K |
|
320
Kraft Heinz
KHC
$31.4B
| $8K | ﹤0.01% |
221
+35
| +19% | +$1.27K |
|
321
LKQ Corp
LKQ
$8.27B
| $8K | ﹤0.01% |
+135
| New | +$8K |
|
322
MillerKnoll
MLKN
$1.39B
| $8K | ﹤0.01% |
549
+6
| +1% | +$87 |
|
323
Ingevity
NGVT
$2.1B
| $8K | ﹤0.01% |
+141
| New | +$8K |
|
324
Novartis
NVS
$245B
| $8K | ﹤0.01% |
+79
| New | +$8K |
|
325
Onto Innovation
ONTO
$5.21B
| $8K | ﹤0.01% |
+72
| New | +$8K |
|